Cas:29366-76-5 6-(m-tolyl)-1,3,5-triazine-2,4-diamine manufacturer & supplier

We serve Chemical Name:6-(m-tolyl)-1,3,5-triazine-2,4-diamine CAS:29366-76-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-(m-tolyl)-1,3,5-triazine-2,4-diamine

Chemical Name:6-(m-tolyl)-1,3,5-triazine-2,4-diamine
CAS.NO:29366-76-5
Synonyms:6-(m-tolyl)-1,3,5-triazine-2,4-diamine
Molecular Formula:C10H11N5
Molecular Weight:201.22800
HS Code:2933699090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:506.5ºC at 760mmHg
Density:1.296g/cm3
Index of Refraction:1.676
PSA:90.71000
Exact Mass:201.10100
LogP:2.17380

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-(m-tolyl)-1,3,5-triazine-2,4-diamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-(m-tolyl)-1,3,5-triazine-2,4-diamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-(m-tolyl)-1,3,5-triazine-2,4-diamine Use and application,6-(m-tolyl)-1,3,5-triazine-2,4-diamine technical grade,usp/ep/jp grade.


Related News: ChenMed, which presently operates more than 80 Chen, Dedicated and JenCare Senior Medical Centers in 12 states, has successfully vaccinated 100 percent of doctors and staff at over 70 of its practices by educating and encouraging care team members and patients alike through its ongoing and multifaceted VaxTheNation® initiative. (2-pyridin-2-yl-ethyl)-pyrimidin-4-yl-amine manufacturers BetterUp currently works with more than 370 organizations, of which more than 40 have European headquarters. New partners in the region include bp, which will be onboarding employees this month to support the mental fitness and well-being of the company’s teams. 9(10H)-Anthracenone, 1,8-dihydroxy-10-phenyl- suppliers The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. 5-((2E,4E)-5-([2,2′-bi(1,3-dithiolylidene)]-4-yl)penta-2,4-dien-1-ylidene)-1,3-diethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione vendor & factory.